Spruce Point Capital Management · activist-deck
iRhythm Technologies, Inc. (IRTC)
101 pages · 5 arc beats · 3 loops
iRhythm Technologies, Inc. (IRTC)
Spruce Point Capital Management · 2025-08 arc beats above · slides in the middle · loops below · scroll → 3 LOOPS
15101520253035404550556065707580859095100101
Deck intelligence map
5 coverage by narrative range · generated from this deck JSON
Narrative range 74 total
Metadata
Components
Metrics
Tools
Frameworks
Beats
Loops
Villain Critique 7 slides 100% 7/7 slides 100% 7/7 slides · 33 hits — 0/7 slides
42.9% 3/7 slides · 4 hits 42.9% 3/7 slides 100% 7/7 slides — 0/7 slides
Expose Contradiction 17 slides 100% 17/17 slides 100% 17/17 slides · 114 hits — 0/17 slides
— 0/17 slides
64.7% 11/17 slides 100% 17/17 slides 70.6% 12/17 slides Thesis Headline 16 slides 100% 16/16 slides 100% 16/16 slides · 112 hits — 0/16 slides
— 0/16 slides
62.5% 10/16 slides 100% 16/16 slides — 0/16 slides
Problem Statement 17 slides 100% 17/17 slides 100% 17/17 slides · 119 hits — 0/17 slides
— 0/17 slides
82.4% 14/17 slides 100% 17/17 slides — 0/17 slides
Preempt Rebuttal 17 slides 100% 17/17 slides 100% 17/17 slides · 127 hits — 0/17 slides
— 0/17 slides
82.4% 14/17 slides 100% 17/17 slides — 0/17 slides
Slide inventory
101 every slide · same image gating as the playbook
01
The slide uses a speech bubble to mock the company's product positioning.name_villain
Open slide detailBeat · Villain Critique
03
The slide uses alternating row colors to distinguish sections.front_matter
Open slide detailBeat · Villain Critique
04
The slide uses a precedent table to establish credibility and track record.cite_precedent
Open slide detailBeat · Villain Critique
05
Standard Spruce Point Capital Management branding.front_matter
Open slide detailBeat · Villain Critique
06
The slide serves as a cover/introductory summary for an activist short report.frame_problem
Open slide detailBeat · Villain Critique
07
This is a classic activist short-seller thesis slide, combining product commoditization arguments with regulatory/safety risk exposure.name_villain
Open slide detailBeat · Villain Critique
08
The slide uses a red border to emphasize the critical nature of the content.name_villain
Open slide detailBeat · Expose Contradiction
09
Includes a direct excerpt from a government petition to support the claim of an investigation into executive knowledge.expose_contradiction
10
Uses a direct quote from a legal motion to frame the company's defensive legal strategy as an admission of material weakness.expose_contradiction
11
The slide uses a yellow callout box to emphasize the core thesis. It highlights a disconnect between company claims and actual physician sentiment.diagnose_problem
12
The slide is structured as two distinct sections: one on business headwinds and one on management credibility.diagnose_problem
13
Includes a direct quote from a regulatory consultant to emphasize the severity of the risk.frame_problem
14
The slide uses a table format to contrast specific company claims/results with Spruce Point's critical analysis.expose_contradiction
15
The slide uses a numbered list format to systematically enumerate risks, typical of activist short reports.diagnose_problem
16
Spruce Point Capital Management branding (pine tree logo).transition
17
Uses a 'not equal' symbol to visually represent the contradiction between management's pitch and reality.expose_contradiction
18
The slide uses direct excerpts from an FDA warning letter to build a case against the company's product safety and transparency.expose_contradiction
19
Uses direct excerpts from an FDA Warning Letter to substantiate claims of regulatory non-compliance.expose_contradiction
20
Uses direct quotes from an official regulatory document to build a case of negligence.expose_contradiction
21
The slide uses whistleblower testimony (FE 3) to contradict company claims regarding the device's real-time monitoring capabilities.expose_contradiction
Open slide detailBeat · Expose Contradiction
22
Uses a specific employee testimonial to validate the activist's thesis regarding product development issues.expose_contradiction
Open slide detailBeat · Expose Contradiction
23
Uses legal excerpts to build a narrative of corporate malfeasance.expose_contradiction
Open slide detailBeat · Expose Contradiction
24
The slide uses a 'before-after' or 'claim-vs-reality' structure to expose a contradiction in management's public statements.expose_contradiction
Open slide detailBeat · Expose Contradiction
26
The slide uses a 'villain critique' approach to undermine the company's core value proposition (AI and device tech).name_villain
Open slide detailBeat · Thesis Headline
27
Uses a table structure to systematically debunk four specific marketing claims.expose_contradiction
Open slide detailBeat · Thesis Headline
28
The slide uses red text to emphasize the sequential list of limitations (First, Second, etc.) within the quoted text.expose_contradiction
Open slide detailBeat · Thesis Headline
29
Uses proprietary survey data (n=100) and a Tegus interview to support the thesis of commoditization.diagnose_problem
Open slide detailBeat · Thesis Headline
30
Includes survey data (n=100) and a testimonial from a Philips Healthcare director.compare_peers
Open slide detailBeat · Thesis Headline
31
Uses red boxes to highlight the specific data points being contrasted.expose_contradiction
Open slide detailBeat · Thesis Headline
32
Uses direct quotes from CEO and CFO to frame the product as commoditized and delayed.expose_contradiction
Open slide detailBeat · Thesis Headline
33
Uses red boxes to highlight specific evidence of AI commoditization in the market.preempt_rebuttal
Open slide detailBeat · Thesis Headline
34
The slide highlights specific text in red to emphasize the FDA's finding of miscalculation.expose_contradiction
Open slide detailBeat · Thesis Headline
35
Uses a combination of a specific case study (Mayo Clinic) and industry commentary (DAIC blog) to support the thesis.name_villain
Open slide detailBeat · Thesis Headline
36
Uses a direct quote from an earnings call to frame a 'new news' event as a material threat.expose_contradiction
Open slide detailBeat · Thesis Headline
37
The slide uses a mix of news snippets and clinical study results to demonstrate that competitors have already achieved FDA clearance and multi-sensor capabilitiexpose_gap
Open slide detailBeat · Thesis Headline
38
Uses a hub-and-spoke diagram to show feature overlap; red checkmarks added by the activist to emphasize the critique.name_villain
Open slide detailBeat · Thesis Headline
39
Uses Glassdoor testimonials to undermine management's narrative.expose_contradiction
Open slide detailBeat · Thesis Headline
40
The slide features the Spruce Point Capital Management logo (pine tree).frame_problem
Open slide detailBeat · Thesis Headline
41
The slide uses direct quotes from an FDA Form 483 to build a case of regulatory negligence.expose_contradiction
Open slide detailBeat · Problem Statement
42
Uses direct quotes from a legal complaint to build a case of corporate misconduct.expose_contradiction
Open slide detailBeat · Problem Statement
43
Uses a quote from an earnings call to frame a 'villain' narrative regarding regulatory compliance.expose_contradiction
Open slide detailBeat · Problem Statement
44
Includes a process diagram from the IPO prospectus with a red box highlight added by the activist.expose_contradiction
Open slide detailBeat · Problem Statement
45
The slide uses direct quotes from interviews to undermine the company's defense regarding their product safety and reporting obligations.expose_contradiction
Open slide detailBeat · Problem Statement
46
Uses red text to emphasize critical phrases in employee quotes.expose_contradiction
Open slide detailBeat · Problem Statement
47
The slide uses a table format to present qualitative evidence (employee testimonials) to support the thesis of operational failure.expose_contradiction
Open slide detailBeat · Problem Statement
48
Uses excerpts from an FDA Form 483 and a legal complaint to undermine the company's technical credibility.expose_contradiction
Open slide detailBeat · Problem Statement
49
The slide uses survey data to undermine the company's marketing claims regarding AI differentiation.expose_contradiction
Open slide detailBeat · Problem Statement
50
Uses a 'before-after' or 'contradiction' structure to undermine corporate claims.expose_contradiction
Open slide detailBeat · Problem Statement
51
Uses a 'quote-and-critique' structure to expose potential regulatory non-compliance.expose_contradiction
Open slide detailBeat · Problem Statement
52
The slide highlights a potential reputational and operational risk for iRhythm by contrasting their offshoring practices with customer preferences.expose_contradiction
Open slide detailBeat · Problem Statement
53
The slide uses a 'before-after' or 'contradiction' framing to highlight a discrepancy between management narrative and actual headcount distribution.expose_contradiction
Open slide detailBeat · Problem Statement
54
Uses a 'guilt by association' framework by linking iRhythm's vendor (Techindia) to a prior legal settlement involving the same vendor.expose_contradiction
Open slide detailBeat · Problem Statement
55
Uses a side-by-side comparison to highlight regulatory risk.expose_contradiction
Open slide detailBeat · Problem Statement
56
Uses an iceberg diagram to visualize the discrepancy between reported and total complaints.expose_contradiction
Open slide detailBeat · Problem Statement
57
Spruce Point Capital Management branding (pine tree logo).frame_problem
Open slide detailBeat · Problem Statement
58
Uses a quote from the CEO to highlight the discrepancy between the company's 27M+ TAM claim and the 6.5M current market reality.expose_contradiction
Open slide detailBeat · Preempt Rebuttal
59
Uses a red 'not equal' symbol to visually represent the contradiction.expose_contradiction
Open slide detailBeat · Preempt Rebuttal
60
The slide uses official medical guidelines to undermine the thesis of companies relying on asymptomatic screening.preempt_rebuttal
Open slide detailBeat · Preempt Rebuttal
61
The slide uses direct quotes from survey respondents to build a case against the company's business model of expanding monitor usage to PCPs.preempt_rebuttal
Open slide detailBeat · Preempt Rebuttal
62
The slide uses a survey of 100 cardiologists to undermine the value proposition of the company's automated reporting service.expose_contradiction
Open slide detailBeat · Preempt Rebuttal
63
Uses a combination of expert testimony and industry guidelines to undermine the company's growth narrative.preempt_rebuttal
Open slide detailBeat · Preempt Rebuttal
64
Uses a table-like structure to present arguments against the company's value proposition.preempt_rebuttal
Open slide detailBeat · Preempt Rebuttal
65
Uses a direct quote from an earnings call to highlight a perceived contradiction in management's market sizing narrative.expose_contradiction
Open slide detailBeat · Preempt Rebuttal
66
The slide uses red boxes and underlines to highlight specific data points and text that contradict the iRhythm thesis.expose_contradiction
Open slide detailBeat · Preempt Rebuttal
67
The slide uses a forest plot to visualize meta-analysis data for sensitivity and specificity.preempt_rebuttal
Open slide detailBeat · Preempt Rebuttal
68
The slide uses a red callout box to explicitly link Apple's recent FDA approvals to iRhythm's historical business model.expose_contradiction
Open slide detailBeat · Preempt Rebuttal
69
Uses direct quotes from CEO and CMO to expose the contradiction.expose_contradiction
Open slide detailBeat · Preempt Rebuttal
70
Uses red boxes to draw attention to the author's name and current employment status.expose_contradiction
Open slide detailBeat · Preempt Rebuttal
71
Uses a collection of news clippings to build a case for Apple's medical market entry.preempt_rebuttal
Open slide detailBeat · Preempt Rebuttal
72
Uses a Reuters news clipping as an authority citation to support the activist thesis.expose_contradiction
Open slide detailBeat · Preempt Rebuttal
73
Uses a 'before-after' style contradiction to highlight management's lack of transparency.expose_contradiction
Open slide detailBeat · Preempt Rebuttal
74
Spruce Point Capital Management branding (pine tree logo).frame_situation
Open slide detailBeat · Preempt Rebuttal
75
Includes a valuation bridge/comparison table and a specific callout regarding Q2 2025 earnings.size_opportunity
Open slide detailLoop · Cost Of Inaction
76
The slide uses a red-and-white table format to highlight negative catalysts for the company.diagnose_problem
Open slide detailLoop · Cost Of Inaction
77
Uses a calculation bridge to isolate core revenue growth by stripping out PCP contributions.expose_contradiction
Open slide detailLoop · Cost Of Inaction
78
The slide uses red highlighting in the table to draw attention to unfavorable trends in 2023 and 2024.diagnose_problem
Open slide detailLoop · Cost Of Inaction
79
Uses a combination of regulatory precedent (HHS) and employee testimony (Glassdoor) to build a case for potential fraud.expose_contradiction
Open slide detailLoop · Cost Of Inaction
80
Uses a combination of direct quotes from company filings/calls and a causal logic flow to build the bear case.expose_contradiction
Open slide detailLoop · Cost Of Inaction
81
Uses a 'villain critique' style to contrast management claims with actual performance data.expose_contradiction
Open slide detailLoop · Cost Of Inaction
82
Uses a table to contrast historical management claims with subsequent outcomes.expose_contradiction
Open slide detailLoop · Cost Of Inaction
83
The slide highlights that despite 10x revenue growth, iRhythm's margins have barely improved, contrasting this with BioTelemetry's superior profitability at simcompare_peers
Open slide detailLoop · Cost Of Inaction
84
Uses a 'not equal' symbol to visually represent the contradiction between CEO statements.expose_contradiction
Open slide detailLoop · Cost Of Inaction
85
Uses red 'X' and flag icons to signify negative disclosure trends.expose_contradiction
Open slide detailLoop · Cost Of Inaction
87
Uses a red-and-white table structure to highlight specific instances of alleged corporate malfeasance.expose_contradiction
Open slide detailLoop · Hypothesis Test
88
Uses a combination of CEO quote and legal document excerpt to highlight a contradiction.expose_contradiction
Open slide detailLoop · Hypothesis Test
89
Uses a 'Pitch vs Reality' framework to undermine management credibility.expose_contradiction
Open slide detailLoop · Hypothesis Test
90
Uses red underlining to highlight specific regulatory violations in the source text.expose_contradiction
Open slide detailLoop · Hypothesis Test
91
The slide uses a red-background table to visually emphasize the 'troubling' nature of the associations.name_villain
Open slide detailLoop · Hypothesis Test
92
Uses visual markers (red X and ?) to annotate corporate policy text as evidence of failure.expose_contradiction
Open slide detailLoop · Hypothesis Test
93
Uses a comparison table to show the reduction in frequency of negative keywords (criminal, fraud, etc.) between two versions of a corporate document.expose_contradiction
Open slide detailLoop · Hypothesis Test
94
Uses a timeline-style table for management turnover and a list with red 'X' marks to indicate board departures.expose_contradiction
Open slide detailLoop · Hypothesis Test
95
The slide uses red text to emphasize critical phrases within the quotes.expose_contradiction
Open slide detailLoop · Hypothesis Test
96
The slide uses a table of individual insider holdings and a stock chart to visualize the 'opportunistic' selling behavior.expose_contradiction
Open slide detailLoop · Hypothesis Test
97
Spruce Point Capital Management branding (pine tree logo).summarize
Open slide detailLoop · Hypothesis Test
98
Includes footnotes regarding share counts, cash, and debt adjustments.analyze_data
99
The slide highlights a disconnect between the stock's recent price performance and the underlying analyst consensus.show_valuation_bridge
100
The slide argues that iRhythm's technology is commoditized and less rigorous than peers, justifying a lower valuation multiple.compare_peers
101
The slide uses a 'services business' argument to justify a lower revenue multiple (2x-4x) compared to medical device peers.show_valuation_bridge